Koyfin Home > Directory > Health Care > Albireo Pharma Inc > Capital Expenditures

Albireo Pharma Inc Capital Expenditures Chart (ALBO)

Albireo Pharma Inc annual/quarterly Capital Expenditures from 2016 to 2020.
  • Albireo Pharma Inc Capital Expenditures for the quarter ending June 06, 2020 was $0m a -424.36% increase of 0m year over year
  • Albireo Pharma Inc Capital Expenditures for the last 12 months ending June 06, 2020 was $0m a -150.24% increase of 0m year over year
  • Albireo Pharma Inc Annual Capital Expenditures for 2019 was $-1m a 88.70% decrease of 0m from 2018
  • Albireo Pharma Inc Annual Capital Expenditures for 2018 was $0m a -211.48% increase of 0m from 2017
  • Albireo Pharma Inc Annual Capital Expenditures for 2017 was $0m a 98.42% decrease of 0m from 2016
Other Cash Flow Metrics:
  • Albireo Pharma Inc Cash Flow from Operations for the quarter ending December 12, 2018 was $-10m a 110.98% decrease of -11m year over year
  • Albireo Pharma Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-10m a 91.45% decrease of -10m year over year
  • Albireo Pharma Inc Total Revenue for the quarter ending September 09, 2018 was $0m a 100.42% increase of 0m year over year
View Chart On Koyfin

Quarterly ALBO Capital Expenditures Data

06/2020$0m
12/2019$0m
09/2019$0m
06/2019$0m
12/2018$0m
09/2018$0m
06/2018$0m
03/2018$0m
12/2017$0m
09/2017$0m

Annual ALBO Capital Expenditures Data

2019$-1m
2018$0m
2017$0m
2016$0m
2014$0m